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Abstract
Introduction: We sought to investigate whether the use of balanced solutions reduces the incidence of
hyperchloraemic acidosis without increasing the risk for intracranial hypertension in patients with severe brain injury.
Methods: We conducted a single-centre, two-arm, randomised, double-blind, pilot controlled trial in Nantes,
France. Patients with severe traumatic brain injury (Glasgow Coma Scale score ≤8) or subarachnoid haemorrhage
(World Federation of Neurosurgical Society grade III or higher) who were mechanically ventilated were randomised
within the first 12 hours after brain injury to receive either isotonic balanced solutions (crystalloid and hydroxyethyl
starch; balanced group) or isotonic sodium chloride solutions (crystalloid and hydroxyethyl starch; saline group) for
48 hours. The primary endpoint was the occurrence of hyperchloraemic metabolic acidosis within 48 hours.
Results: Forty-two patients were included, of whom one patient in each group was excluded (one consent
withdrawn and one use of forbidden therapy). Nineteen patients (95%) in the saline group and thirteen (65%) in
the balanced group presented with hyperchloraemic acidosis within the first 48 hours (hazard ratio = 0.28, 95%
confidence interval [CI] = 0.11 to 0.70; P = 0.006). In the saline group, pH (P = .004) and strong ion deficit
(P = 0.047) were lower and chloraemia was higher (P = 0.002) than in the balanced group. Intracranial pressure
was not different between the study groups (mean difference 4 mmHg [-1;8]; P = 0.088). Seven patients (35%) in
the saline group and eight (40%) in the balanced group developed intracranial hypertension (P = 0.744). Three
patients (14%) in the saline group and five (25%) in the balanced group died (P = 0.387).
Conclusions: This study provides evidence that balanced solutions reduce the incidence of hyperchloraemic
acidosis in brain-injured patients compared to saline solutions. Even if the study was not powered sufficiently for
this endpoint, intracranial pressure did not appear different between groups.
Trial registration: EudraCT 2008-004153-15 and NCT00847977
The work in this trial was performed at Nantes University Hospital in Nantes, France.
Introduction
Brain injuries remain a major concern for public health
services, particularly because of the high mortality rate
and long-term disabilities that result [1]. In the early
stages of caring for brain-injured patients, therapies are
focused on minimising secondary brain injuries that are
centrally involved in determining outcomes [2]. Intracra-
nial hypertension (ICH) is the most frequent cause of
death and secondary brain insults after brain injury [3].
The maintenance of adequate cerebral perfusion pressure
(CPP), which is associated with control of intracranial
pressure (ICP), is the cornerstone of treating the ion defi-
cit associated with brain ischaemia in brain-injured
patients. Infusion of hypo-osmotic solutions, which
increases cerebral swelling, should be avoided after brain
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injury [4,5]. Current recommendations are to use isotonic
solutions in patients with severe brain injury [6,7], with
isotonic sodium chloride (0.9% saline solution) being the
mainstay of therapy. Isotonic sodium chloride solutions
induce hyperchloraemic metabolic acidosis and have
side effects including haemostatic alterations, cognitive
dysfunction and ileus [8].
Hyperchloraemia is relatively common in critically ill
patients, and it is now commonly accepted that chloride-
rich fluids are the primary cause of hyperchloraemic
acidosis in critically ill patients [9]. In a before-after
study, a chloride-restrictive strategy was associated with a
significant decrease in renal failure in critically patients
and significantly affected electrolyte and acid-base status
[10]. In a post hoc analysis of a retrospective study in TBI
patients receiving isotonic sodium chloride solutions for
basal infusion [11], 65% of the patients experienced
hyperchloraemia. Chloride channels regulate cell oedema
[12], and it could be hypothesised that dyschloraemia
contributes to brain swelling.
Isotonic balanced solutions are now available and
include crystalloids as well as hydroxyethyl starch (HES)
solutions. In these isotonic solutions, the use of malate
and acetate allows the reduction of chloride concentration
while ensuring isotonicity. Balanced solutions could thus
reduce the incidence of hyperchloraemic metabolic acido-
sis. Balanced solutions decrease the rate of hyperchlorae-
mic acidosis in healthy volunteers [13,14] and during
perioperative care compared with saline solutions [15-17].
To date, no data regarding isotonic balanced solutions for
brain-injured patients have been published, and use of
these solutions is therefore not recommended in this
setting. The use of a balanced solution would appear to be
attractive in brain-injured patients who are prone to ion
homeostasis disruption, notably through hormonal dys-
function such as diabetes insipidus or cerebral salt-wasting
syndrome or through alterations of chloride-dependent
channels such as the NKCC1 transporter [18,19]. We
postulated that infusion of isotonic balanced solutions
instead of saline solutions would diminish the incidence of
hyperchloraemic acidosis without increasing ICP in
patients with severe brain injury hospitalised in the ICU.
Materials and methods
Ethical approval and study design
This randomised, double-blind, parallel, controlled study
was approved by the Institutional Review Board of
Tours, France (Région Centre, Ouest-1) (Trial registration:
EudraCT 2008-004153-15 and NCT00847977). Patients
were enrolled after their next-of-kin provided written
informed consent. Retrospective consent, when available,
was obtained from patients. Patients were enrolled from
October 2008 to October 2010, when recruitment was
completed in three ICUs of the Nantes University Hospital.
Patient population
Patients with severe traumatic brain injury (TBI) (Glasgow
Coma Scale score ≤8) on mechanical ventilation within
the first 12 hours after brain injury were included. During
recruitment, we refined the eligibility criteria by including
patients with subarachnoid haemorrhage (SAH) at World
Federation of Neurosurgical Societies (WFNS) grade III or
worse (amendment of 26 July 2010). Exclusion criteria
were multiple trauma, pregnancy, azotaemia above 200
μmol/L, kalemia less than 2.5 mmol/L, calcaemia less than
1.8 mmol/L, HES hypersensitivity, haemophilia or von
Willebrand disease. Patients were also excluded when
hypertonic saline solutions (HSSs) were used prior to
inclusion or within the first 6 hours of the study start.
Randomisation
Patients were randomised in a 1:1 ratio to either the
balanced group (allocated solutions, crystalloids:
Isofundine/HES: Tetraspan; B Braun Medical, Melsungen,
Germany) or the saline group (allocated solutions, crystal-
loids: 0.9% saline solution/HES: HEAfusine, B Braun
Medical) (Table 1). Randomisation was performed in
blocks of eight by a computerised number generator list
provided by a statistician not involved in the determina-
tion of eligibility or in the assessment of outcomes. The
study packs were sealed in identical sequentially numbered
boxes containing the entire treatment for each patient.
Each “Iso-TC treatment packet” contained Isofundine
or 0.9% saline solution (sheath labelled “crystalloid”),
Tetraspan or HEAfusine (sheath labelled “HES”), and a
sheet was also provided for the administration schedule.
Patients, investigators, members of the monitoring board
and medical and nursing staff were unaware of the
patients’ treatment assignment.
Conduct of the study
Administration of the studied solutions began immediately
after patient admission and lasted 48 hours. The attributed
crystalloid was administered as a continuous intravenous
infusion (30 ml/kg/day). The attending physician could
administer optional boli (20 ml/kg of the attributed crys-
talloid or 10 ml/kg of the attributed HES over 20 minutes).
Apart from blood products, other intravenous fluids were
not allowed during the first 48 hours. After the 48th hour,
fluid infusions were not controlled.
General care for brain-injured patients
Brain-injured patients were mechanically ventilated and
were sedated with fentanyl and midazolam (0.9% saline
solution as drug-carrier solution). Patients were kept in
a semirecumbent position. Continuous enteral nutrition
was initiated 24 hours after brain injury [20]. The rate
of enteral nutrition (Fresubin; Fresenius-Kabi, France)
was increased every 8 hours until it reached 83 ml/h
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(2,000 kcal/day) (see Additional file 1 for full description).
Parenteral nutrition was started on day 7 in patients
intolerant to gastric feeding. Secondary brain injuries
were prevented by avoiding hypoxaemia and anaemia
(haemoglobin <10 g/dl), maintaining body temperature
between 36.0°C and 37.0°C, ensuring normoglycaemia
and normocapnia (between 4.6 and 5.5 kPa). ICP was
monitored with an intraparenchymal probe placed in the
most affected side (Codman; Johnson & Johnson, Rayn-
ham, MA, USA) in patients with severe brain injuries who
had abnormal computed tomography (CT) scans and were
considered at increased risk of ICH [21]. Extraventricular
drainage was used in case of hydrocephalus detected on
CT scans. Patients were monitored by invasive arterial
pressure and mean arterial pressure (MAP) was measured
up to the brain for the calculation of CPP. CPP was main-
tained above 60 mmHg with boli of the attributed isotonic
solutions (crystalloid or HES; see Table 1) and continuous
infusion of norepinephrine (diluted in 0.9% saline solu-
tion). Mannitol (bolus of 0.5 g/kg repeatable once in case
of poor ICP control, ICP >20 mmHg, after 30 minutes;
maximum dose: 1 g/kg) was used to control episodes of
ICH. When control of ICH was poor, sodium thiopental
was used with a loading dose (2 to 3 mg/kg) followed by
continuous administration (2 to 3 mg/kg/h) adapted to
ICP evolution and to serum level monitoring (blood level
of thiopental between 20 and 30 μg/ml). A continuous
infusion of HSS (20% saline solution) was started in case
of refractory ICH [11]. When control of ICH was poor,
decompressive craniectomy or therapeutic hypothermia
was discussed with the neurosurgical team. The evolution
of brain injuries was assessed by CT within the first
72 hours after brain injury.
Data handling
The following data were recorded: general characteristics,
including demography, initial GCS score, WFNS grade,
time from tracheal intubation to study inclusion, vaso-
pressor therapy, fluid challenges and surgical procedures
prior to inclusion. Natraemia, chloraemia, kalaemia, mag-
nesemia, phosphatemia, ionized calcaemia, azotaemia,
albuminaemia, osmolarity, lactataemia, arterial gases and
haematocrit were measured immediately before and at 6,
12, 24, 36 and 48 hours after starting the treatment. The
total volume of fluid administered and the evolution of
ICP were recorded during the study period (48 hours).
Episodes of ICH, modifications on the control CT (bleed-
ing, herniation or brain swelling), osmotherapy and/or
barbiturate use, transfusion, vasopressor use, time to
achieve more than 50% of goal calories of enteral nutri-
tion, duration of mechanical ventilation, length of ICU
stay and mortality rate were also recorded in the ICU.
Safety was assessed by recording adverse events.
Definitions
Strong ion difference (SID) was defined as (Na+ + K+ + Ca2+
+ Mg2+) - (Cl- + lactate) mEq/L [22]. Hyperchloraemic
metabolic acidosis was defined as SID below 40 mEq/L
associated with chloraemia above 108 mmol/L according to
local laboratory normal ranges.
Endpoints
The primary endpoint was the occurrence of hyperchlor-
aemic metabolic acidosis within 48 hours. The secondary
outcomes were electrolyte status, ICP, rate of ICH epi-
sodes, volume of intravenous fluid, duration of vasopressor
therapy, duration of mechanical ventilation, length of
ICU stay and death in the ICU.
Statistical analysis
To the best of our knowledge, the incidence of hyperchlor-
aemic acidosis in brain-injured patients has not been
documented to date. We have thus performed a post hoc
Table 1 Electrolyte composition of studied fluids.
Saline group Balanced
group
Crystalloid solutions 0.9% saline
solution
Isofundine
Sodium (mmol/L) 153 140
Potassium (mmol/L) 0 4.0
Calcium (mmol/L) 0 2.5
Magnesium (mmol/L) 0 1.0
Chloride mmol/L) 153 127
Acetate (mmol/L) 0 24
Malate (mmol/L) 0 5.0




Acid titre <2 <2




Molar substitution 0.5 0.42
Average molecular weight (Da) 200,000 130,000
Sodium (mmol/L) 153 140
Potassium (mmol/L) 0 4.0
Calcium (mmol/L) 0 2.5
Magnesium (mmol/L) 0 1.0
Chloride (mmol/L) 153 118
Acetate (mmol/L) 0 24
Malate (mmol/L) 0 5.0




Acid titre <2 <2
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analysis of the chloraemia values collected in a study of
TBI patients with ICH receiving HSS [11]. We found a
65% incidence of hyperchloraemia within the first four
days in the ICU before any HSS infusion. The sample size
needed to detect a 45% decrease in the incidence of hyper-
chloraemic acidosis, assuming a basal rate of 65% in a
two-sided test performed with a statistical power of 85%
and an a risk of 0.05, was 20 patients in each group in this
pilot study. Taking into account exclusions, and in an
attempt to keep the power of the study, 42 patients
(21 patients in each group) were included.
The full analysis set (FAS) of patients was the primary
population used for statistical analysis of efficacy (per-
protocol analysis) and was defined as all randomised
patients treated with the study drug who did not receive
forbidden therapy (HSS infusion). All randomised
patients (the intention-to-treat (ITT) population) were
analysed for the primary outcome and safety variables.
We first verified that in all patients the incidence of
hyperchloraemic acidosis at 48 hours was significantly
decreased in the balanced group compared with the
control group using Fisher’s exact test. Six patients
experienced hyperchloraemic acidosis prior to inclusion
(four in the saline group and two in the balanced group).
We therefore decided a posteriori to perform two
complementary sensitivity analyses. The first excluded
patients with preexisting hyperchloraemic acidosis, the
second censored the preinclusion biological values (SID,
chloraemia) and the third consisted of evaluating the
effect of balanced solutions on the primary outcome on
the basis of a logrank test.
For secondary outcomes, linear mixed models were used
with group effect, time effect and interaction between time
effect and group effect. We first investigated the interac-
tion between time effect and group effect. For the values
with no significant interaction, the mean difference
between groups within the study period was provided. For
the value with a significant interaction between time effect
and group effect, comparisons were performed indepen-
dently and P values were calculated at each time point.
Residual analysis was used to assess the appropriateness of
the models (including normality and homoscedasticity).
Nonparametric data are expressed as medians and inter-
quartile ranges (IQRs). Categorical data are expressed as
numbers and percentages. c2 test, Fisher’s exact test and
Wilcoxon rank-sum test were used as appropriate.
A subgroup analysis considering severe TBI patients
was performed a posteriori using the same analytical
strategy. Regarding ICP evolution, subgroup analysis
considering the 15 patients with ICH was performed.
All statistical tests were two-sided. Statistical analyses
were performed using SAS 9.1 statistical software (SAS
Institute, Cary, NC, USA).
Results
Study population
Of the 42 patients included, 41 were included in the
ITT analysis (one consent withdrawal) and 40 were
included in the FAS analysis (exclusion of one patient
who received HSS infusion within the first six hours;
Figure 1). Demographic data are provided in Table 2
(see Additional file, Table S1, for the demographics of
the FAS population). The total volume of fluid infusion
was not altered by study group (Table 3). The total
amount of chloride infusion was lower in the balanced
group than in the saline group (median 744 mmol (IQR
= 572 to 952) and median 918 mmol (IQR = 689 to
1,148), respectively; P = 0.014) (Table 3). Two patients
in the saline group and one patient in the balanced
group received one bolus of 500 ml of colloid diluted in
a saline solution (Gelofusine; B Braun Medical) out of
the study protocol, and data from these patients were
kept in the statistical analysis.
Efficacy outcomes
In the ITT population, 19 patients (90%) in the saline
group and 10 patients (50%) in the balanced group had
hyperchloraemic acidosis within the first 48 hours (P =
0.004). The Kaplan-Meier estimators at hour 48 were
90% (range = 83% to 92%) in the saline group and 50%
(range = 31% to 72%) in the balanced group, with a
hazard ratio (HR) for hyperchloraemic acidosis in the
balanced group of 0.24 (95% CI = 0.10 to 0.59; P = 0.003)
(Figure 2A).
In the FAS analysis, 18 patients (90%) in the saline
group and 10 patients (50%) in the balanced group had
hyperchloraemic acidosis within the first 48 hours (P =
0.01). The Kaplan-Meier estimators at hour 48 were
90% (range = 73% to 98%) in the saline group and 50%
(range = 31% to 72%) in the balanced group, with a HR
for hyperchloraemic acidosis in the balanced group of
0.28 (95% CI = 0.11 to 0.70; P = 0.006) (Figure 2B).
Two sensitivity analyses did not change the results.
The HR for hyperchloraemic acidosis in the balanced
group was 0.18 (95% CI = 0.06 to 0.55; P = 0.002)
when the patients with acidosis prior to inclusion were
excluded, and it was 0.25 (95% CI = 0.09 to 0.69; P =
0.008) with a censorship of the biological values (SID,
chloraemia) prior to inclusion. In the subgroup of TBI
patients, the HR for hyperchloraemic acidosis in the
balanced group was 0.30 (95% CI = 0.12 to 0.80; P =
0.015) (Figure 2C).
Secondary efficacy outcomes
The pH was lower in the saline group than in the
balanced group (mean difference = -0.03 (-0.05 to -0.01);
P = 0.004) (Figure 3A). Patients in the saline group had a
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lower SID than the balanced group (mean difference =
-1.55 mEq/L (-3.09 to -0.02); P = 0.047) (Figure 3B).
Chloraemia was higher in the saline group than in the
balanced group (mean difference = 4.8 mmol/L (1.9 to
7.6); P = 0.002) (Figure 3C). Compared with the balanced
group, patients in the saline group had lower phospha-
taemia (mean difference = -0.12 mmol/L [-0.21 to -0.04);
P = 0.008) (Figure 3D). From hour 0 to hour 48, albumi-
naemia and partial pressure of carbon dioxide in arterial
blood (PaCO2) were not altered in the saline group com-
pared with the balanced group (Figures 3E and 3F). The
reported differences in the acid-base status between
groups were not significantly modified in the subgroup
of TBI patients (Additional file, Figure S1). The results
for base excess, effective SID, simplified anion gap and
corrected anion gap are provided in the Additional file,
Table S2. The blood osmolarity was higher in the saline
group than in the balanced group (mean difference =
7 mOsmol/L (1 to 14); P = 0.024) (Figure 4A). The
natraemia levels were higher in the saline group than in
the balanced group (mean difference = 2 mmol/L (0
to 4); P = 0.036) (Figure 4B). ICP was not altered in
the study group (mean difference = 4 mmHg (-1 to 8);
P = 0.088) (Figure 4C). In the subgroup of TBI patients,
blood osmolarity, natraemia and ICP were not altered in
the study group (see Additional file, Figure S2). Among
the entire population, seven patients (35%) in the saline
group and eight patients (40%) in the balanced group
developed ICH (P = 0.744) (Table 4). In the subgroup of
patients who developed ICH, ICP was not altered by
study group (mean difference = -4 mmHg (-11 to 2);
P = 0.20). (Additional file, Figure S3).
Safety assessment
Safety outcomes were assessed for the ITT patient
population (Table 4). Decompressive craniectomy was
Figure 1 Flowchart of the study. GCS: Glasgow Coma Scale score, FAS: full analysis set; HES: hydroxyethyl starch; HSS: hypertonic saline
solution, SAH: subarachnoid haemorrhage, TBI: traumatic brain injury, WFNS: World Federation of Neurological Societies.
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Table 2 Baseline characteristicsa
Characteristics Intention-to-treat population TBI patients
Saline (N = 21) Balanced (N = 20) Saline (N = 18) Balanced (N = 18)
Age (years), median (IQR) 51 (25 - 68) 49 (26 - 75) 47 (28-57) 49 (27-77)
Male, N (%) 15 (71) 17 (85) 13 (72) 16 (89)
Diagnosis, N (%)
Traumatic brain injury 19 (90) 18 (90) / /
Subarachnoid haemorrhage 2 (10) 2 (10)
Glasgow Coma Scale score on scene, median (IQR) 8 (7 - 9) 7 (6 - 9) 7 (6-8) 7 (6-8)
Surgical procedures, N (%)
Haematoma/contusion evacuation 9 (43) 4 (20) 8 (44) 4 (22)
Extraventricular drainage 2 (10) 2 (10) 0 0
Transfusion, median (IQR)
Red blood cells, units 4 (19) 3 (15) 4 (22) 3 (17)
Fresh frozen plasma, units 3 (14) 0 3 (17) 0
Norepinephrine infusion on admission, N (%) 8 (38) 7 (35) 7 (39) 7 (39)
Fluid infusion prior to inclusion, median (IQR)
Crystalloids (NaCl 0.9%), ml 1000 (500 -1000) 1000 (500 - 1500) 500 (500 -1000) 1000 (500 -1500)
Colloids, ml 0 (0 - 500) 0 (0 - 500) 0 (0 - 500) 0 (0 - 500)
Time from brain injury to inclusion (hours) median (IQR) 5 (3 - 7) 5 (4 - 12) 4 (3-6) 5 (4-6)
Biological status upon inclusion
Hyperchloraemic acidosis, N (%) 4 (19) 2 (10) 4 (22) 2 (11)
Osmolarity (mOsm/L), median (IQR) 303 (295 - 319) 302 (296 - 319) 306 (299-328) 306 (300-319)
Natraemia (mmol/L), median (IQR) 140 (138-142) 139 (137-141) 140 (138-141) 139 (137-141)
Chloraemia (mmol/L), median (IQR) 106 (104 - 110) 106 (101 - 107) 106 (104-111) 106 (100-107)
Kalemia (mmol/L), median (IQR) 3.6 (3.4 - 3.9) 3.7 (3.5 - 4.1) 3.7 (3.4-3.9) 3.7 (3.5-4.1)
Ionized calcaemia (mmol/L), median (IQR) 1.10 (1.07 - 1.14) 1.11 (1.07 - 1.18) 1.10 (1.08-1.12) 1.11 (1.06-1.18)
Magnesemia (mmol/L), median (IQR) 0.86 (0.72 - 0.95) 0.81 (0.75 - 0.88) 0.82 (0.76-0.92) 0.83 (0.73-0.92)
Phosphoremia (mmol/L), median (IQR) 0.86 (0.67 - 1.07) 0.85 (0.74 - 1.14) 0.88 (0.70-1.10) 0.82 (0.73-1.13)
Lactataemia (mmol/L), median (IQR) 1.4 (1.1 - 2.1) 1.7 (1.1 - 2.7) 1.5 (1.2-2.2) 2.0 (1.1-2.7)
Azotaemia (μmol/L), median (IQR) 66 (56-73) 67 (58-71) 65 (56-72) 67 (60-71)
Albuminaemia (g/L), median (IQR) 36 (32 - 41) 37 (34 - 39) 34 (32-41) 36 (34-39)
pH, median (IQR) 7.38 (7.33 - 7.44) 7.39 (7.32 - 7.45) 7.36 (7.31-7.41) 7.39 (7.31-7.45)
SID (mmol/L), median (IQR) 39 (35 - 42) 39 (39 - 41) 40 (37-41) 39 (37-41)
aIQR: interquartile range; TBI: traumatic brain injury; Strong Ion Difference (SID) = (Na + K + Ca + Mg) - (Cl + lactate).







Na administration (mmol) H0 to H48 918 (689 to 1,148) 840 (630 to 1,050) 0.228
Cl administration (mmol) H0 to H48 918 (689 to 1,148) 744 (572 to 952) 0.014
Crystalloids (ml) H0 to H6 2,000 (1,000 to 2,000) 1,000 (500 to 2,000) 0.255
H6 to H24 2,000 (1,500 to 2,000) 1,500 (1,500 to 2,000) 0.530
H24 to H48 2,000 (1,500 to 2,000) 2,000 (1,500 to 2,000) 0.755
H0 to H48 5,000 (4,500 to 6,000) 5,000 (4,000 to 6,000) 0.448
Hydroxyethyl starch solutions (ml) H0 to H6 0 (0 to 500) 0 (0 to 500) 0.613
H6 to H24 0 (0 to 500) 0 (0 to 500) 0.563
H24 to H48 0 (0 to 0) 500 (0 to 1,000) 0.060
H0 to H48 500 (0 to 1,500) 1,000 (500 to 1,500) 0.228
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Figure 2 Kaplan-Meier curves for hyperchloraemic acidosis. Hyperchloraemic acidosis was defined as the association of hyperchloraemia
(>108 mmol/L) with strong ion difference (SID) (<40 mmol/L). SID = (Na + K + Ca + Mg) - (Cl + lactate). Na; sodium, K; potassium; Ca: calcium;
Mg: magnesium; Cl: chloride.
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performed before ICU admission in one patient (5%) in
the balanced group compared with one patient (5%) in
the saline group (P = 0.972) (Table 4). Three patients
(14%) in the saline group died (two with ICH (10%) and
one due to care withdrawal (5%)), compared with five
patients (25%) in the balanced group (two patients with
ICH (10%) and three patients due to care withdrawal
(15%)) (P = 0.387). No patients died during the study
periodThere is no need to provide this information
since it is stated that 3 patients died in the saline group
and five in the other group.
Discussion
The present study shows that balanced solutions, in
comparison with isotonic saline solutions, reduced the
occurrence of hyperchloraemic acidosis in brain-injured
Figure 3 Time course of acid-base status in the saline group and the balanced group. Hyperchloraemic acidosis was defined as the
association of hyperchloraemia (>108 mmol/L) with strong ion difference (SID) <40 mmol/L. SID = (Na + K + Ca + Mg) - (Cl + lactate). {AU: OK
to delete Kaplan? OK Or are words missing?}According to Stewart et al. (A) pH is independently influenced by three biological values: first,
the SID (B) and chloraemia (C); second, the total weak acid concentration composed of phosphor (D) and albumin (E); and third, the partial
pressure of carbon dioxide in arterial blood (PaCO2) (F). Results are given as medians (IQR). *P < 0.05 versus saline group (significant group
effect). Na: sodium, K: potassium, Ca: calcium, Mg: magnesium, Cl: chloride.
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patients. Balanced solutions were not associated with
ICP alteration or ICH episodes.
According to Stewart et al., hydrogen ion concentra-
tion (pH) is independently influenced by three biological
variables: (1) PaCO2, (2) total weak acid concentration
(labelled Atot) composed of phosphate and albumin and (3)
SID corresponding to the difference between strong cations
and strong anions [22]. According to Stewart et al.’s
concept, sodium chloride solutions are responsible for
metabolic acidosis through a decrease in SID [23-25].
Thus, administration of drugs with sodium chloride exci-
pient (such as cloxacillin, midazolam or fentanyl) partici-
pate in the decrease in SID, which could partially explain
the 50% rate of hyperchloraemic acidosis in the
balanced group. The concentration of chloride in 0.9%
saline solutions surpasses the normal ranges for blood
Figure 4 Time course of (A) blood osmolarity, (B) natraemia and (C) intracranial pressure in the saline group and the balanced group.
Results are given as medians (IQR). *P < 0.05 versus saline group (significant group effect).
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chloraemia [26]. A correlation between hyperchlorae-
mia and base excess has been described in patients
undergoing major surgery [16]. Balanced solutions
reduce the risk of hyperchloraemic acidosis in elderly
patients undergoing major surgery [27,28]. Our results
reveal that balanced solutions decrease the risk of
hyperchloraemic acidosis in patients with severe brain
injury.
At this time, there is increasing evidence that chloride-
rich solutions alter the outcomes of critical ill patients
[9]. In animal models, chloride-rich solutions decreased
the glomerular filtration rate by inducing renal vasocon-
striction [29,30]. In a before-after study, the restriction of
chloride-rich solutions was associated with a decrease in
kidney failure in critically ill patients [10]. Saline-rich
solutions alter the coagulation cascade and increase
intraoperative blood loss when compared with balanced
solutions [31-34]. Hyperchloraemic acidosis also decreases
gastric and pyloric motility and could reduce gastric
mucosal perfusion [28]. In the present study, balanced
solutions prevented hyperchloraemic acidosis but altered
neither kidney function (assessed by diuresis and azotae-
mia) nor gut motility (assessed by the time to achieve
more than 50% of enteral nutrition goal calories).
Prevention of hypo-osmolarity is a major goal for the
prevention and treatment of ICH. Indeed, hypo-osmolarity
induces brain ischaemia resulting from the swelling of
perivascular astrocytic cells and also increases ICP and the
volume of brain injury [35]. Thus, administration of hypo-
osmolar solutions should be avoided in brain-injured
patients [6,7]. The isotonicity of the balanced solutions
may authorize their utilization in the neuro-ICU, but few
Table 4 Safety assessmenta













Patients with an episode of ICH, n (%) 8 (38) 8 (40) 0.905 6 (33) 8 (44) 0.494
Number of ICH episode per patient, mean ± SD 3 ± 5 1 ± 2 0.912 3 ± 6 1 ± 1 0.957
Management of ICH, n (%)
Osmotherapy (mannitol) 8 (38) 7 (35) 0.837 6 (33) 7 (39) 0.729
Barbiturate 7 (33) 6 (30) 0.819 5 (28) 6 (33) 0.718
Decompressive craniectomy 1 (5) 1 (5) 0.972 1 (6) 1 (6) 1
Therapeutic hypothermia 0 (0) 0 (0) 1 0 (0) 0 (0) 1
Modifications on CT, n (%)
Bleeding 1 (5) 2 (10) 0.52 1 (6) 2 (11) 1
Herniation 0 (0) 1 (5) 0.3 0 (0) 1 (6) 1
Brain swelling 4 (19) 2 (10) 0.413 3 (17) 1 (6) 0.602
In ICU transfusion, n (%)
Red blood cells 7 (33) 4 (20) 0.336 7 (39) 4 (22) 0.278
Fresh frozen plasma 5 (24) 1 (5) 0.089 5 (28) 1 (6) 0.178
Duration of norepinephrine infusion, days, median (IQR) 5 (2 to 7) 4 (2 to 7) 0.676 3 (1 to 4) 4 (2 to 6) 0.503
Potassium administration, n (%) 13 (60) 11 (55) 0.654 10 (56) 10 (56) 1
Calcium administration, n (%) 4 (20) 2 (10) 0.661 3 (17) 2 (11) 1
Azotaemia, (mol/L), median (IQR)
Day 1 59 (56 to 68) 60 (50 to 67) 0.879 64 (57 to 74) 67 (59 to 71) 0.975
Day 2 60 (54 to 65) 56 (46 to 64) 0.289 58 (56 to 67) 62 (52 to 68) 0.734
Diuresis, L/day, median (IQR)


















Time to achieve >50% of goal calories of enteral nutrition, days,
median (IQR)
4 (3 to 5) 3 (3 to 11) 0.911 4 (3 to 6) 3 (3 to 11) 1
Duration of mechanical ventilation, days, median (IQR) 12 (5 to 18) 12 (8 to 19) 0.823 10 (2 to 18) 10 (7 to 19) 0.76
ICU length of stay, days, median (IQR) 19 (10 to 24) 16 (8 to 21) 0.521 18 (10 to 24) 14 (7 to 21) 0.591
Death in ICU, n (%) 3 (14) 5 (25) 0.387 2 (11) 5 (28) 0.402
Refractory ICH 2 (10) 2 (10) 1 (6) 2 (11)
Care withdrawal 1 (5) 3 (15) 1 (6) 3 (17)
aCT: computed tomography, ICH: intracranial hypertension, IQR: interquartile range, ITT: intention to treat; TBI: traumatic brain injury.
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data are available in this setting to date. In the present
study, the balanced solutions failed to induce hyperosmo-
larity, and the blood osmolarity was lower in the balanced
group than in the saline group. This lower osmolarity in
the balanced group may prove important because the
maintenance of normal osmolarity is an asset when caring
for the brain-injured patients. However, neither ICP evolu-
tion nor the rate of ICH were different between the study
groups. These results could be explained by the impact of
balanced solutions on chloraemia, which is a key regulator
of cell volume [10]. Chloride ion efflux prevents cell swel-
ling in hypotonic media [12,36]. The lower chloraemia
observed in the balanced group could have increased the
phenomenon of chloride ion efflux, limiting brain swelling
despite decreased osmolarity compared with the saline
group. According to this hypothesis, it has previously been
described that a sodium lactate-based hyperosmolar solu-
tion more significantly decreased ICP than an equivalent
osmotic load of chloride-rich solution [35]. Prevention of
hyperchloraemia appears to be an asset for the prevention
of ICH in patients with severe brain injury.
There is a controversy about the safety of HES, parti-
cularly regarding its effects on coagulation [37]. These
concerns could prove to be important in the setting of
brain-injured patients. Recently, the Neuro-Intensive
Care and Emergency Medicine (NICEM) Section of the
European Society of Intensive Care Medicine consensus
document stated that HES is not recommended in the
context of brain injury [38]. However, this consensus
statement was not available when our study started.
Moreover, the doses of HES used in each group in our
study were below the maximum daily threshold of
20 ml/kg/day.
This study has several limitations. First, given the
small number of included SAH patients, the conclusions
are valid mainly for the TBI patients. Second, we did
not report any differences between groups regarding
side effects of hyperchloraemic acidosis. Third, the
reported biological differences may not be clinically rele-
vant. Prolonged infusion of 0.9% saline solution may alter
clinical outcomes. Fourth, the balanced solution did not
alter neurological recovery, and we cannot rule out the
theoretical issue regarding the risk of ICH with balanced
solutions. However, this pilot study was not powered to
evaluate these endpoints.
Conclusions
The use of balanced solutions reduces the incidence of
hyperchloraemic acidosis in brain-injured patients. ICP
evolution and the rate of ICH in brain-injured patients
did not appear to be different between groups. The
safety and impact of balanced solutions on neurological
recovery, as well as the potential side effects of balanced
solutions, should be investigated in a large, randomised
trial comparing balanced solutions and isotonic saline
solutions in TBI patients.
Key messages
• Balanced solutions decrease the incidence of
hyperchloraemic acidosis in patients with severe
brain injury compare with saline solutions.
• Balanced solutions decrease natraemia and blood
osmolarity in patients with severe brain injury.
• Larger studies are required to investigate the
effects of balanced solutions on brain swelling and
neurological recovery.
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